Download the 2011 Program Book - Traditional Poster ... - ismrm

Poster Sessions
1 Bioquimica i Biologia Molecular, Universitat Autònoma Barcelona, Cerdanyola del Vallès, Barcelona, Spain; 2 Centro de
Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Cerdanyola del Vallès, Barcelona,
Spain; 3 Servei de Ressonància Magnètica Nuclear, Universitat Autònoma de Barcelona, Cerdanyola del Valles, Barcelona, Spain
979. Can T 1 or T 2 -Weighted MRI Measurements Detect Irreversible Electroporation Ablation Zones in Liver
Tumors?
Yue Zhang 1,2 , Yang Guo 2 , Jodi Nicolai 2 , Rachel A. Klein 2 , Reed A. Omary 2,3 , Andrew C. Larson 2,3
1 Bioengineering, University of Illinois at Chicago, Chicago, IL, United States; 2 Radiology, Northwestern University, Chicago, IL,
United States; 3 Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, United States
980. Multi-Parametric MRI Assessment of the Anti-Angiogenic Effects of Liposome-Encapsulated Glucocorticoids
Ewelina Kluza 1 , Marieke Heisen 2 , Sophie Schmid 1 , Daisy W. J. van Der Schaft 3 , Raymond M Schiffelers 4 , Gert Storm 4 ,
Bart M. ter Haar Romeny 2 , Gustav J. Strijkers 1 , Klaas Nicolay 1
1 Biomedical NMR, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands;
2 Biomedical Image Analysis, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands;
3 Biomechanics & Tissue Engineering, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven,
Netherlands; 4 Department of Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
981. High Resolution Pre-Clinical MRI in Murine Braf-Induced Thyroid Tumor Targeted Therapy
Aime T. Franco 1 , Ronald A. Ghossein 2 , H. Carl Le 3 , Jason A. Koutcher, 4 , Jame Fagin 5
1 Medicine & Human Human Oncology & Pathogenesis Program, MSKCC, New York, NY, United States; 2 Pathology, MSKCC, New
York, NY, United States; 3 Medical Physics, MSKCC, New York, NY, United States; 4 Medicine, MSKCC; 5 Medicine & Human
Oncology & Pathogenesis Program, MSKCC
982. A Multifunctional Nanoparticle Platform for Imaging Guided Therapy of Cancer
Anita Gianella 1,2 , Peter A. Jarzyna 1 , Venkatesh Mani 1 , Sarayu Ramachandran 1 , Claudia Calcagno 1 , Gert Storm 3 ,
David P. Cormode 1 , Victor L. Thijssen 4 , Arjan W. Griffioen 4 , Zahi A. Fayad 1 , Willem J. M. Mulder 1
1 Translational & Molecular Imaging Institute, Mount Sinai School of Medicine, New York, NY, United States; 2 Centro Cardiologico
Monzino, Milano, Italy; 3 Utrecht Institute for Pharmaceutical Science, Utrecht, Netherlands; 4 Department of Medical Oncology, VU
University Medical Center, Amsterdam, Netherlands
983. Evaluation of Gemcitabine as an Alternative Treatment to Temozolomide for High Grade Gliomas.
Benjamin Lemasson 1 , Stefanie Galbán 2 , Terence M.Willians 2 , Fei Li 1 , Kevin A. Heist 1 , Timothy D. Johnson 3 , Alnawaz
Rehemtulla 1,2 , Craig J. Galbán 1 , Brian Dale Ross 1
1 Radiology, University of Michigan, Ann Arbor, MI, United States; 2 Radiation Oncology, University of Michigan, Center for
Molecular Imaging, Ann Arbor, MI, United States; 3 Biostatistics, University of Michigan, Ann Arbor, MI, United States
984. Comparison of Response to OXi4503 Therapy in Subcutaneous & Orthotopic Liver Metastasis Models using
Susceptibility & Diffusion MRI
Peter Johnson 1 , Simon Walker-Samuel 2 , Vineeth Rajkumar 3 , Mathew Robson 3 , Mark F. Lythgoe* 2 , Barbara Pedley* 3
1 Institute of Cancer, University College London, London, United Kingdom; 2 UCL Centre for Advanced Biomedical Imaging,
Department of Medicine & Institute of Child Health, University College London, London, United Kingdom; 3 Institute of Cancer,
University College London, United Kingdom
985. Combining DCE-MRI & DW-MRI for Evaluating the Early Response of a Hypoxia-Activated Chemotherapy
Julio Cardenas 1 , Yuguo Li 2 , Christine a Howison 3 , Jean-Philippe Galons 4 , Amanda F Baker 5 , Mark D Pagel 6
1 Chemistry & Biochemistry, University of Arizona, Tucson, AZ, United States; 2 Radiology, Case Western Reserve University,
Cleveland, OH, United States; 3 Arizona Research Laboratories, University of Arizona, Tucson, AZ, United States; 4 Radiology,
University of Arizona, Tucson, AZ, United States; 5 Hematology/Oncology, Arizona Cancer Center, University of Arizona, Tucson,
AZ, United States; 6 Biomedical Engineering & Chemistry & Biochemistry, University of Arizona, Tucson, AZ, United States
986. Integration of Diffusion Weighted Magnetic Resonance Imaging Data Into a Simple Mathematical Model of
Tumor Growth
Nkiruka C. Atuegwu 1 , Daniel C. Colvin 1 , Mary E. Loveless 1,2 , Lei Xu 3 , John C. Gore 1,4 , Thomas E. Yankeelov 1,4
1 Institute of Imaging Science, Vanderbilt University, Nashville, TN, United States; 2 Biomedical Engineering, Vanderbilt University,
Nashville, TN, United States; 3 Biostatistics, Vanderbilt University, Nashville, TN, United States; 4 Radiology, Vanderbilt University,
Nashville, TN, United States
987. Native T 1 is a Generic Imaging Biomarker of Response to Chemotherapy in Neuroblastoma
Yann Jamin 1 , Elizabeth R. Cullis 2 , Lynsey Vaughan 2 , Hannah Webber 2 , Jessica K. R. Boult 1 , Lauren C. Baker 1 , Dow-
Mu Kow 1 , Louis Chesler 2 , Simon P. Robinson 1
1 CRUK & EPSRC Cancer Imaging Centre, The Institute of Cancer Research & Royal Marsden NHS Trust, Sutton, United Kingdom;
2 Paediatric Oncology, The Institute of Cancer Research, Sutton, United Kingdom
128